Preventive Medicine

July 6, 2012

Mayo Clinic in the News Weekly Highlights

By Mystery User

July 6, 2012 Mayo Clinic in the News is a weekly highlight summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations New […]

View full entry

Tags: Academy Health Annual Research Meeting, David Claypool, Dr. Rafael Fonseca, Hematologic Malignancies Program, Huffington Post, Huffington Post Canada, KAAL, Mall of America, mammograms, Matthew Sztajnkrycer, Mayo Clinic Cancer Center, Mayo Clinic Center for the Science of Health Care Delivery


June 29, 2012

Mayo Clinic in the News Weekly Highlights

By Mystery User

June 29, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations NPR […]

View full entry

Tags: arthritis, CBS, Dr. Edward Laskowski, Dr. Eric Matteson, Dr. James Levine, Dr. Richard Hurt, Dr. Thomas Boyce, heart disease, Mayo Clinic Children's Center, Mayo Clinic's Sports Medicine Center, nicotine addiction, NPR


June 21, 2012

Mayo Clinic in the News Weekly Highlights

By Mystery User

June 21, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations NY […]

View full entry

Tags: alzheimer's disease, American Society of Clinical Oncology, Center for Medicare and Medicaid Innovation, Chemotherapy, Chicago Tribune, Dr. James A. Levine, Dr. John Black, Dr. John Noseworthy, Esther H. Krych, Florida Times-Union, ginseng, government funding


June 19, 2012

For Some Skin Cancers, Targeted Drug Hits the Mark

By Mystery User

Modified dosing schedules may limit the side effects and are being investigated, noted Dr. Aleksandar Sekulic of the Mayo Clinic, who led the BCC study. In the phase II trial, 30 percent of patients with metastatic disease had a partial response, and 43 percent of patients with locally advanced disease had a complete or partial […]

View full entry

Tags: complete response, dosing schedules, Dr. Aleksander Sekulic, NCI Bulletin, partial response


June 18, 2012

MNTX Opioid Improves Bowel Movement

By Mystery User

As per a research, which has been published in the Mayo Clinic Proceedings, has found that methylnaltrexone (MNTX), a peripheral opioid is quite effective in treating bowel function in critically ill patients. The drug has been created by Dr. Jonathan Moss at the University of Chicago. It seems that the drug has proved its efficacy […]

View full entry

Tags: constipation, Dr. Jonathan Moss, Mayo Clinic Proceedings, methylnaltrexone, University of Chicago


June 12, 2012

Statins May Leave Patients With Less Energy: Study

By Mystery User

Tatins — the popular class of cholesterol-lowering drugs — significantly increase the risk of experiencing a drop in energy or becoming unduly tired when exercising, according to new research. The finding stems from work tracking about 1,000 adults, and includes well-known shelf names Pravachol and Zocor, both designed to reduce levels of the so-called “bad” […]

View full entry

Tags: cholesterol, Dr. Scott Wright, Health Day, tatins


June 11, 2012

New Drug Can Fight Inherited Skin Cancer

By Mystery User

There is a new drug to fight skin cancer for the sun-splashed masses of Arizona. The drug, vismodegib, was approved by the Food and Drug Administration in January for people with an advanced form of one type of skin cancer, basal-cell carcinoma. New research unveiled last week by local doctors and other scientists shows that […]

View full entry

Tags: Aleksander Sekulic, Arizona Republic, carcinoma, Food and Drug Administration, New England Journal of Medicine, skin cancer


June 4, 2012

ASCO 2012 Multiple Myeloma Update – Day Three: New Myeloma Treatments

By Mystery User

One of the morning presentations was given by Dr. Melissa Alsina from the H. Lee Moffitt Cancer Center in Tampa, Florida.  Dr. Alsina presented a Phase 2 study of panobinostat in combination with Velcade (bortezomib) and dexamethasone (Decadron)… The panobinostat trial results were reviewed by Dr. Asher Chanan-Khan of the Mayo Clinic in Jacksonville, Florida, in […]

View full entry

Tags: Dr. Asher Chanan-Khan, Dr. Melissa Alsina, H. Lee Moffitt Cancer Center, multiple myeloma, Myeloma Beacon


June 1, 2012

New Class of Cancer Drugs May Be Less Toxic

By Mystery User

The experimental treatment, called T-DM1, is a harbinger of a new class of cancer drugs that may be more effective and less toxic than many existing treatments. By harnessing antibodies to deliver toxic payloads to cancer cells, while largely sparing healthy cells, the drugs are a step toward the “magic bullets” against cancer first envisioned […]

View full entry

Tags: Adcetris, American Society of Clinical Oncology, Dr. Edith Perez, experimental treatment, NY Times, Paul Ehrlich, Seattle Genetics


May 18, 2012

Mayo Clinic in the News Weekly Highlights

By Mystery User

May 18, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations oestreich.karl@mayo.edu […]

View full entry

Tags: ABC News, alzheimer's disease, Chicago Sun-Times, Dr. Farris Timimi, Dr. James Kirkland, Dr. Lyle Joyce, Dr. Ronald Peterson, Dr. Sharonne Hayes, Dr. Thomas Boyce, Dr. Timothy Young, KAAL, KARE11


Contact Us · Privacy Policy